EcoDrugPlus

Cholinergic Receptor, Muscarinic 5b

Ensembl ID : ENSTRUG00000018108
Gene Symbol: CHRM5B
1 Cross references
189 Possible Orthologues:

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSTRUG00000005062
Gene Symbol: F2R
3 Cross references
216 Possible Orthologues:

Coagulation Factor Iiia

Ensembl ID : ENSTRUG00000030995
Gene Symbol: F3A
1 Cross references
198 Possible Orthologues:

Coagulation Factor Iiia

Ensembl ID : ENSTRUG00000003042
Gene Symbol: F3A
1 Cross references
198 Possible Orthologues:

Coagulation Factor Vii, Like

Ensembl ID : ENSTRUG00000020579
Gene Symbol: F7L
2 Cross references
78 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSTRUG00000004411
Gene Symbol: F10
4 Cross references
240 Possible Orthologues:

Coagulation Factor Xi-Like

Ensembl ID : ENSTRUG00000023496
Gene Symbol: LOC105417160
2 Cross references
214 Possible Orthologues:

Coagulation Factor Xi-Like

Ensembl ID : ENSTRUG00000023065
Gene Symbol: LOC101079451
2 Cross references
214 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSTRUG00000009022
Gene Symbol: CCDC6
4 Cross references
207 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSTRUG00000003445
Gene Symbol: MMPF1
3 Cross references
306 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSTRUG00000006553
Gene Symbol: CSF1R
3 Cross references
63 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSTRUG00000008096
Gene Symbol: CRHR1
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).